Glipizide
- Product NDC
- 50090-5377
- 11-digit product format
- 500905377
- Labeler code
- 50090
- Product ID
- 50090-5377_e9587166-99b1-4d1c-b496-4a64b66495a6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA203499
- Marketing category
- ANDA
- Marketing start
- 2018-12-01
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5377-0 | Glipizide | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 3 |
| 50090-5377-2 | Glipizide | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5377 | GLIPIZIDE TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS] | 3 | Legacy NDC, 2 package rows | 20210303_d09880af-afdb-470a-8731-fcc885c52467.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5377-0 | 50090537700 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5377-0) | 2020-11-19 | 0000-00-00 | No | No | Current |
| 50090-5377-2 | 50090537702 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5377-2) | 2020-11-19 | 0000-00-00 | No | No | Current |